Metabolic Effects of DPP-4 Related to Its Enzymatic Activity Despite DPP-4 having a relatively restricted substrate preference (Figure 1), a large number of peptides, proteins, and chemokines still fulfill the criteria and could be predicted to be suitable substrates, and indeed, many have been shown to be cleaved by DPP-4 in pharmacological kinetic, in vitro or animal studies, often using high substrate concentrations (3638)
J Alzheimers Dis (2017) 60(3):85966
These technologies work best for mild to moderate laxity, especially in areas like the face, neck, arms, and abdomen
Different clinical syndromes associated with the deficiency of this enzyme have been described and they include: Hemolysis induced by drugs
GLP-1R agonists (GLP-1RAs) can effectively reduce blood glucose and body weight, and have beneficial cardiovascular and mortality outcomes in randomized controlled trials